Literature DB >> 15790310

Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.

George Koutsodontis1, Eleftheria Vasilaki, Wan-Chih Chou, Paraskevi Papakosta, Dimitris Kardassis.   

Abstract

In the present study, we have investigated mechanisms of transcriptional co-operation between proteins that belong to the tumour suppressor p53 and Sp (specificity protein) families of transcription factors. Such mechanisms may play an important role in the regulation of genes containing binding sites for both classes of transcription factors in their promoters. Two of these genes were analysed in the present study: the cyclin-dependent kinase inhibitor p21Cip1 gene and the PUMA (p53-up-regulated mediator of apoptosis) gene. We found that Sp1 and Sp3, but not Sp2, co-operate functionally with p53, p73 and p63 for the synergistic transactivation of the p21Cip1 promoter in Drosophila Schneider SL2 cells that lack endogenous Sp factors. We also found that Sp1 strongly transactivated the PUMA promoter synergistically with p53, whereas deletion of the Sp1-binding sites abolished the transactivation by p53. Using p53 mutant forms in GST (glutathione S-transferase) pull-down assays, we found that the C-terminal 101 amino acids of p53, which include the oligomerization and regulatory domains of the protein, are required for the physical interactions with Sp1 and Sp3, and that deletion of this region abolished transactivation of the p21Cip1 promoter. Utilizing truncated forms of Sp1, we established that p53 interacted with the two transactivation domains A and B, as well as the DNA-binding domain. Our findings suggest that Sp factors are essential for the cellular responses to p53 activation by genotoxic stress. Understanding in detail how members of the p53 and Sp families of transcription factors interact and work together in the p53-mediated cellular responses may open new horizons in cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790310      PMCID: PMC1175122          DOI: 10.1042/BJ20041980

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Cdk inhibitors in development and cancer.

Authors:  J W Harper; S J Elledge
Journal:  Curr Opin Genet Dev       Date:  1996-02       Impact factor: 5.578

Review 2.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

3.  Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.

Authors:  M Marin; A Karis; P Visser; F Grosveld; S Philipsen
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

4.  Identification of a novel p53 functional domain that is necessary for efficient growth suppression.

Authors:  K K Walker; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 5.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

6.  p21 is a component of active cell cycle kinases.

Authors:  H Zhang; G J Hannon; D Casso; D Beach
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

7.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.

Authors:  S Lee; B Elenbaas; A Levine; J Griffith
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

8.  An alternatively spliced form of the transcription factor Sp1 containing only a single glutamine-rich transactivation domain.

Authors:  S P Persengiev; J D Saffer; D L Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

9.  The polyproline region of p53 is required to activate apoptosis but not growth arrest.

Authors:  D Sakamuro; P Sabbatini; E White; G C Prendergast
Journal:  Oncogene       Date:  1997-08-18       Impact factor: 9.867

10.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

View more
  26 in total

1.  A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.

Authors:  Bi-He Cai; Chung-Faye Chao; Hwang-Chi Lin; Hua-Ying Huang; Reiji Kannagi; Jang-Yi Chen
Journal:  J Biochem       Date:  2016-01-27       Impact factor: 3.387

2.  Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.

Authors:  Sanjit K Dhar; Jitbanjong Tangpong; Luksana Chaiswing; Terry D Oberley; Daret K St Clair
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

3.  SP1 plays a pivotal role for basal activity of TIGAR promoter in liver cancer cell lines.

Authors:  Shubiao Zou; Zhidong Gu; Peihua Ni; Xiangfan Liu; Jiayi Wang; Qishi Fan
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

4.  p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells.

Authors:  Mei-Juan Wang; Dong-Sheng Pei; Guo-Wei Qian; Xiao-Xing Yin; Qian Cheng; Lian-Tao Li; Hui-Zhong Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-05-25

5.  Aging and Protein Kinases.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest.

Authors:  Oshrat Hershkovitz Rokah; Ofer Shpilberg; Galit Granot
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

7.  Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha.

Authors:  Esther Vorovich; Edward A Ratovitski
Journal:  Aging (Albany NY)       Date:  2008-12-09       Impact factor: 5.682

8.  Regulation of Sp1 by cell cycle related proteins.

Authors:  Alicia Tapias; Carlos J Ciudad; Igor B Roninson; Véronique Noé
Journal:  Cell Cycle       Date:  2008-09-24       Impact factor: 4.534

9.  Sp1 and p73 activate PUMA following serum starvation.

Authors:  Lihua Ming; Tsukasa Sakaida; Wen Yue; Anupma Jha; Lin Zhang; Jian Yu
Journal:  Carcinogenesis       Date:  2008-06-25       Impact factor: 4.944

10.  Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences.

Authors:  Marie Brázdová; Timo Quante; Lars Tögel; Korden Walter; Christine Loscher; Vlastimil Tichý; Lenka Cincárová; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.